Linzagolix rapidly reduces heavy menstrual bleeding in women with uterine fibroids: An analysis of the PRIMROSE 1 & 2 trials

To study the timing of the effect of linzagolix, an oral GnRH antagonist, on significant reduction in heavy menstrual bleeding (HMB) in women with uterine fibroids. The study used pooled data from PRIMROSE1 and PRIMROSE2, two double-blind, similar placebo-controlled trials of linzagolix in US and Eu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Fertility and sterility 2025-01
Hauptverfasser:	Donnez, Jacques, Becker, Christian, Mangler, Mandy, Paszkowski, Maciej, Paszkowski, Tomasz, St-Pierre, Julien, Ionescu-Ittu, Raluca, Boolell, Mitra, Bestel, Elke, Hori, Satoshi, Petraglia, Felice
Format:	Artikel
Sprache:	eng
Schlagworte:	GnRH antagonist heavy menstrual blood loss Linzagolix onset of action uterine fibroids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!